The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients

Background Antireflux therapy may lead to recovery of impaired mucosal integrity in gastro‐esophageal reflux disease (GERD) patients as reflected by an increase in baseline impedance. The study objective was to evaluate the effect of endoscopic fundoplication and proton pump inhibitor (PPI) PPI ther...

Full description

Saved in:
Bibliographic Details
Published in:Neurogastroenterology and motility 2015-02, Vol.27 (2), p.220-228
Main Authors: Rinsma, N. F., Farré, R., Bouvy, N. D., Masclee, A. A. M., Conchillo, J. M.
Format: Article
Language:English
Subjects:
Adult
Aged
Endoscopy, Gastrointestinal
Esophageal pH Monitoring
Female
Fundoplication
Gastroesophageal Reflux - drug therapy
Gastroesophageal Reflux - surgery
gastro‐esophageal reflux disease
Heartburn - drug therapy
Heartburn - surgery
heartburn perception
Humans
Male
Middle Aged
mucosal integrity
Proton Pump Inhibitors - therapeutic use
Treatment Outcome
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Antireflux therapy may lead to recovery of impaired mucosal integrity in gastro‐esophageal reflux disease (GERD) patients as reflected by an increase in baseline impedance. The study objective was to evaluate the effect of endoscopic fundoplication and proton pump inhibitor (PPI) PPI therapy on baseline impedance and heartburn severity in GERD patients. Methods Forty‐seven GERD patients randomized to endoscopic fundoplication (n = 32) or PPI therapy (n = 15), and 29 healthy controls were included. Before randomization and 6 months after treatment, baseline impedance was obtained during 24‐h pH‐impedance monitoring. Heartburn severity was evaluated using the GERD‐HRQL questionnaire. Key Results Before treatment, baseline impedance in GERD patients was lower than in healthy controls (p 
ISSN:1350-1925
1365-2982
DOI:10.1111/nmo.12468